Cart
sales@molnova.com
IKK2-IN-9
CAS No. 1266240-89-4
IKK2-IN-9( —— )
Catalog No. M11120 CAS No. 1266240-89-4
IKK2-IN-9 is a potent, selective and orally active IKK2 inhibitor with IC50 of 19 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIKK2-IN-9
-
NoteResearch use only, not for human use.
-
Brief DescriptionIKK2-IN-9 is a potent, selective and orally active IKK2 inhibitor with IC50 of 19 nM.
-
DescriptionIKK2-IN-9 is a potent, selective and orally active IKK2 inhibitor with IC50 of 19 nM, displays 20-fold selectivity over IKK1 (IC50=420 nM); inhibits lipopolysaccharide (LPS) induced TNFα production in human PBMCs with IC50 of 0.22 uM; dose-dependently inhibist the TNF-α response in murine model of acute inflammation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorIκB kinase (IKK)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1266240-89-4
-
Formula Weight394.497
-
Molecular FormulaC20H22N6OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(S)-N-(1-(3-(5-(ethylamino)-8-methyl-8H-imidazo[4,5-d]thiazolo[5,4-b]pyridin-2-yl)phenyl)ethyl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dyckman AJ, et al. Bioorg Med Chem Lett. 2011 Jan 1;21(1):383-6.
molnova catalog
related products
-
IKK2-IN-8
IKK2-IN-8 is a potent, selective IKK2 inhibitor with IC50 of 6 nM.
-
LY2409881 trihydroch...
LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM; IC50 for IKK1 and other common kinases is at least one log higher.
-
MLN120B
MLN120B is a selective and ATP competitive IKKβ inhibitor (IC50: 60 nM).MLN120B almost completely blocks the stimulation of MM.1S, U266, and INA6 cell growth, as well as IL-6 secretion from BMSCs, induced by multiple myeloma cell adherence to BMSCs [1]. MLN120B shows an inhibitory effect on LPS induced NF-κB activation in RAW267.4 cells.
